Hunan Er-Kang Pharmaceutical Co., Ltd (SZSE: 300267)
Health Care · Pharmaceuticals · CN
CN¥3.22
-2.72% today · -21.1% 1Y
Hunan Er-Kang Pharmaceutical Co., Ltd (SZSE: 300267) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $987.98M and employs 1,271 people.
Over the last twelve months the share price has lost 21.1%, trading between 2.78 and 5.11.
Tweenvest scores Hunan Er-Kang Pharmaceutical Co., Ltd across four factors: quality 68/100, value 45/100, growth 29/100. Its strongest factor is quality.
300267 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $987.98M
- Revenue (TTM)
- $153.62M
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- 0.46
- 52-week high
- CN¥5.11
- 52-week low
- CN¥2.78
- Avg volume (3M)
- —
- Shares outstanding
- 2.06B
- Employees
- 1,271
- Next earnings
- —
About Hunan Er-Kang Pharmaceutical Co., Ltd
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
- ISIN
- CNE100001781
- Founded
- 2003
- Listed since
- Sep 27, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.19 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.00 | +0.28% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.00 | +0.29% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.